Valentin Titus Grigorean

Beyond H&E: CDX2 immunohistochemistry in tumor budding assessment of colorectal carcinoma.

BACKGROUND AND OBJECTIVES: Tumor budding (TB) phenomenon is recognized as one of the important adverse prognostic factors of colorectal carcinoma (CRC) and is currently assessed following to the International Tumor Budding Consensus Conference (ITBCC) recommendations on routine H...